CoreAge Rx vs Goldspan Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Goldspan Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 76 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Goldspan Health a bad call — it's best for readers evaluating a clinician-led program who will obtain the current prescription price, pharmacy assignment and refund terms before ordering. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Goldspan Health |
|---|---|---|
| Brief Score | 94/100 (A) | 76/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm current price Earlier listing: from $229 per 28-day cycle. Current medication charge and supply period not confirmed. Full price detailsCompounded semaglutide offered. Current medication quote unknown; earlier observed from $229 per 28-day cycle for compounded semaglutide |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm current price Earlier listing: from $299 per 28-day cycle. Current medication charge and supply period not confirmed. Full price detailsCompounded tirzepatide offered. Current medication quote unknown; earlier observed from $299 per 28-day cycle for compounded tirzepatide |
| Coverage | US only; restrictions by state, confirmed at intake | All 50 states advertised; the terms qualify access by therapy, state and medical history |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Goldspan Health: Earlier four-week prices remain historical. Current medication prices, supply periods and renewal terms require a new quote through the present Goldspan clinical service.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.